Riken
Amoy Diagnostics CDx Gets Japanese Approval to ID NSCLC Patients Eligible for Tepmetko
The Japanese Ministry of Health, Labor, and Welfare has approved AmoyDx's PLC Panel for use in identifying NSCLC patients with MET exon 14 skipping alterations.
Opossum Change
Researchers from Riken have used CRISPR to edit marsupial genomes, as Technology Review reports.
AmoyDx PCR Panel Receives Japanese Approval as CDx for Non-Small Cell Lung Cancer Therapies
The Japanese MHLW approved the real-time PCR-based test as a CDx to detect four driver genes for nine associated NSCLC targeted therapies.
Coronary Artery Disease Loci Identified in Japanese GWAS, Trans-Ancestry Meta-Analysis
Researchers found ancestry-specific risk variants and developed a better polygenic risk score based on a GWAS and subsequent meta-analysis.
Nature Papers Uncover Disease Susceptibility Loci in Japanese Population, Transfer RNA Modification Profiling
In Nature this week: genome-wide association study of 42 diseases among Japanese population, transfer RNA modifications, and more.
Oct 23, 2017
Apr 17, 2017
New Variants Linked to Atrial Fibrillation Risk
Mar 27, 2014
Genomics in the Journals: Mar 27, 2014
Sep 17, 2013